Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Dalhousie University

$20,000.00

Calcium phosphate processing strategies for the delivery of therapeutic agents

EF 2014-15

Résumé
Regenerating bone lost to disease or trauma can be a significant challenge. A chronic bone infection is but one example of a debilitating disease leading to significant bone loss that is both difficult to eliminate, even with local intervention, and a threat to restoration of tissue or related joint function at the diseased site. Calcium phosphates have been recognized for years as good bone grafting materials since they are known to promote new bone growth when implanted in a bone defect. However, processing limitations have typically restricted their use in drug delivery applications. This program seeks to develop, through novel processing approaches, a class of degradable calcium phosphates (calcium polyphosphates) as temporary matrices for actively directing bone regeneration by the body's own cells while proactively combating disease conditions that may be responsible for bone loss. This will be achieved through the strategic incorporation and local release of drugs or therapeutic agents. This proposal builds on the previous development of antibiotic-loaded calcium phosphates, and specifically looks at the ability of these degradable matrices to deliver large molecules (proteins). Creating innovative antimicrobial calcium phosphates in the form of calcium phosphate-silver composite systems with potential broad applicability through processing manipulation is an additional focus of this work, as is enhancing the functional use of these matrices in self-setting calcium phosphate cements. Importantly, the approaches being developed here may serve to improve the quality of life for Canadians requiring such surgical interventions while taking pressure off an overburdened health care system by reducing costs associated with multiple surgeries. This research may also provide an opportunity to grow the medical device industry in Canada. Successful implementation of these strategies could have profound implications as well for the regeneration of complex tissue structures (eg., periodontal tissues around teeth) and the effective treatment of other debilitating bone diseases such as cancer (osteosarcomas).
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Nova Scotia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
238595-2010
Name nom
Filiaggi, Mark
Department département
Applied Oral Sciences,
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2010
Award amount
20000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
5
Nb partie
5
Application title
Calcium phosphate processing strategies for the delivery of therapeutic agents
Keyword
NSERC
Application summary
Regenerating bone lost to disease or trauma can be a significant challenge. A chronic bone infection is but one example of a debilitating disease leading to significant bone loss that is both difficult to eliminate, even with local intervention, and a threat to restoration of tissue or related joint function at the diseased site. Calcium phosphates have been recognized for years as good bone grafting materials since they are known to promote new bone growth when implanted in a bone defect. However, processing limitations have typically restricted their use in drug delivery applications. This program seeks to develop, through novel processing approaches, a class of degradable calcium phosphates (calcium polyphosphates) as temporary matrices for actively directing bone regeneration by the body's own cells while proactively combating disease conditions that may be responsible for bone loss. This will be achieved through the strategic incorporation and local release of drugs or therapeutic agents. This proposal builds on the previous development of antibiotic-loaded calcium phosphates, and specifically looks at the ability of these degradable matrices to deliver large molecules (proteins). Creating innovative antimicrobial calcium phosphates in the form of calcium phosphate-silver composite systems with potential broad applicability through processing manipulation is an additional focus of this work, as is enhancing the functional use of these matrices in self-setting calcium phosphate cements. Importantly, the approaches being developed here may serve to improve the quality of life for Canadians requiring such surgical interventions while taking pressure off an overburdened health care system by reducing costs associated with multiple surgeries. This research may also provide an opportunity to grow the medical device industry in Canada. Successful implementation of these strategies could have profound implications as well for the regeneration of complex tissue structures (eg., periodontal tissues around teeth) and the effective treatment of other debilitating bone diseases such as cancer (osteosarcomas).